Tekijä: Weiguang Huang (ed.); Mingquan Wang (ed.); Jun WANG (ed.); Kun GAO (ed.); Song LI (ed.); Chen Liu (ed.) Kustantaja: Springer (2016) Saatavuus: Noin 16-19 arkipäivää
Tekijä: Beiji Zou (ed.); Min Li (ed.); Hongzhi Wang (ed.); Xianhua Song (ed.); Wei Xie (ed.); Zeguang Lu (ed.) Kustantaja: Springer (2017) Saatavuus: Noin 16-19 arkipäivää
Tekijä: Jing He (ed.); Philip S. Yu (ed.); Yong Shi (ed.); Xingsen Li (ed.); Zhijun Xie (ed.); Guangyan Huang (ed.); Jie (ed. Cao Kustantaja: Springer (2020) Saatavuus: Noin 16-19 arkipäivää
Springer Sivumäärä: 293 sivua Asu: Pehmeäkantinen kirja Painos: 2008 Julkaisuvuosi: 2014, 19.09.2014 (lisätietoa) Kieli: Englanti
In this book, Dr. Li and his author team plan to emphasize why mouse models are useful in vivo systems for understanding disease mechanisms and developing therapeutic strategies in blood cancers. The authors do not intend to cover all types of blood cancers; instead, they will focus on some major ones such as leukemias and lymphomas. However, the authors will try to cover as much as they can the cancer types and point out that many blood cancers need to be studied in mouse disease models although they are still not available at present. A major focus in the book will be to show what we can or cannot learn from mouse disease models and to also show the critical contributions of mouse models in therapeutic drug development.
